Current and future management of serious skin and skin-structure infections
- 1 June 1996
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 100 (6) , 90S-95S
- https://doi.org/10.1016/s0002-9343(96)00111-8
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- International comparative study of cefepime and ceftazidime in the treatment of serious bacterial infectionsJournal of Antimicrobial Chemotherapy, 1993
- Cefepime as treatment for osteomyelitis and other severe bacterial infectionsJournal of Antimicrobial Chemotherapy, 1993
- A non-comparative, multicentre study of cefepime in the treatment of serious bacterial infectionsJournal of Antimicrobial Chemotherapy, 1993
- Low-dosage cefepime as treatment for serious bacterial infectionsJournal of Antimicrobial Chemotherapy, 1993
- Open trial of cefepime (BMY 28142) for infections in hospitalized patientsAntimicrobial Agents and Chemotherapy, 1990
- Activity of cefepime against ceftazidime- and cefotaxime-resistant gram-negative bacteria and its relationship to beta-lactamase levelsAntimicrobial Agents and Chemotherapy, 1989
- Comparison of a new cephalosporin, BMY 28142, with other broad-spectrum beta-lactam antibioticsAntimicrobial Agents and Chemotherapy, 1985